1. Home
  2. WST vs NMR Comparison

WST vs NMR Comparison

Compare WST & NMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • NMR
  • Stock Information
  • Founded
  • WST 1923
  • NMR 1925
  • Country
  • WST United States
  • NMR Japan
  • Employees
  • WST N/A
  • NMR 27344
  • Industry
  • WST Medical/Dental Instruments
  • NMR Investment Bankers/Brokers/Service
  • Sector
  • WST Health Care
  • NMR Finance
  • Exchange
  • WST Nasdaq
  • NMR Nasdaq
  • Market Cap
  • WST 15.2B
  • NMR 16.3B
  • IPO Year
  • WST N/A
  • NMR 1961
  • Fundamental
  • Price
  • WST $214.58
  • NMR $5.57
  • Analyst Decision
  • WST Strong Buy
  • NMR Hold
  • Analyst Count
  • WST 6
  • NMR 1
  • Target Price
  • WST $349.00
  • NMR N/A
  • AVG Volume (30 Days)
  • WST 1.0M
  • NMR 1.1M
  • Earning Date
  • WST 04-24-2025
  • NMR 04-25-2025
  • Dividend Yield
  • WST 0.39%
  • NMR 3.75%
  • EPS Growth
  • WST N/A
  • NMR 110.70
  • EPS
  • WST 6.37
  • NMR 0.74
  • Revenue
  • WST $2,895,800,000.00
  • NMR $12,637,799,087.00
  • Revenue This Year
  • WST $1.24
  • NMR $20.38
  • Revenue Next Year
  • WST $6.56
  • NMR N/A
  • P/E Ratio
  • WST $33.44
  • NMR $7.20
  • Revenue Growth
  • WST N/A
  • NMR 21.16
  • 52 Week Low
  • WST $187.43
  • NMR $4.66
  • 52 Week High
  • WST $372.79
  • NMR $6.99
  • Technical
  • Relative Strength Index (RSI)
  • WST 50.21
  • NMR 46.65
  • Support Level
  • WST $204.79
  • NMR $5.48
  • Resistance Level
  • WST $215.05
  • NMR $5.59
  • Average True Range (ATR)
  • WST 7.23
  • NMR 0.08
  • MACD
  • WST 1.16
  • NMR 0.03
  • Stochastic Oscillator
  • WST 63.32
  • NMR 38.46

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About NMR Nomura Holdings Inc ADR

Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions worldwide including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking which is engaged in advisory, financing, and solutions businesses.

Share on Social Networks: